Overall Status

Recruiting (2)

Suspended (1)

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

AIDS Malignancy Consortium (1)

Joseph Tuscano (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (2)

California Institute for Regenerative Medicine (CIRM) (1)

Seagen Inc. (1)

Study Documents

Intervention Type

drug (3)

biological (2)

procedure (2)

other (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

Recurrent Follicular Lymphoma

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in United States (Bendamustine

Suspended

Grade 1 Follicular Lymphoma
+4 more

Bendamustine Hydrochloride
+13 more

Anchorage, Alaska
+422 more

Feb 2, 2023

HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

Recruiting

HIV Infection
+10 more

Autologous Hematopoietic Stem Cell Transplantation
+7 more

La Jolla, California
+3 more

Dec 7, 2022

Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Sacramento (Bendamustine Hydrochloride, Brentuximab

Recruiting

Recurrent Follicular Lymphoma
Refractory Follicular Lymphoma

Bendamustine Hydrochloride
Brentuximab Vedotin

Sacramento, California

University of California Davis Comprehensive Cancer Center

Dec 17, 2021